- Home
- CYTK vs MMSI Comparison
CYTK vs MMSI Comparison
Compare CYTK & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- MMSI
- Stock Information
- Founded
- CYTK 1997
- MMSI 1987
- Country
- CYTK United States
- MMSI United States
- Employees
- CYTK N/A
- MMSI N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- MMSI Medical/Dental Instruments
- Sector
- CYTK Health Care
- MMSI Health Care
- Exchange
- CYTK Nasdaq
- MMSI Nasdaq
- Market Cap
- CYTK 6.0B
- MMSI 5.8B
- IPO Year
- CYTK 2004
- MMSI 1990
- Fundamental
- Price
- CYTK $48.87
- MMSI $98.22
- Analyst Decision
- CYTK Buy
- MMSI Strong Buy
- Analyst Count
- CYTK 16
- MMSI 10
- Target Price
- CYTK $84.07
- MMSI $105.60
- AVG Volume (30 Days)
- CYTK 1.1M
- MMSI 396.6K
- Earning Date
- CYTK 11-06-2024
- MMSI 10-30-2024
- Dividend Yield
- CYTK N/A
- MMSI N/A
- EPS Growth
- CYTK N/A
- MMSI 19.39
- EPS
- CYTK N/A
- MMSI 2.05
- Revenue
- CYTK $3,219,000.00
- MMSI $1,325,871,000.00
- Revenue This Year
- CYTK N/A
- MMSI $9.36
- Revenue Next Year
- CYTK $795.25
- MMSI $9.02
- P/E Ratio
- CYTK N/A
- MMSI $47.67
- Revenue Growth
- CYTK N/A
- MMSI 8.12
- 52 Week Low
- CYTK $43.21
- MMSI $70.70
- 52 Week High
- CYTK $110.25
- MMSI $108.08
- Technical
- Relative Strength Index (RSI)
- CYTK 44.62
- MMSI 39.43
- Support Level
- CYTK $45.66
- MMSI $101.57
- Resistance Level
- CYTK $49.40
- MMSI $108.08
- Average True Range (ATR)
- CYTK 1.71
- MMSI 2.46
- MACD
- CYTK -0.20
- MMSI -1.05
- Stochastic Oscillator
- CYTK 50.79
- MMSI 20.48
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.